Skip to content

BVPM DISTRIBUTION: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BVPM DISTRIBUTION

BE 0699.860.542
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€739
2024 · -€1,495+€2,233
Equity
€18,609
2024 · €17,871+€739
Cash
€222
2024 · €7+€215
Balance sheet total
€20,739
2024 · €20,430+€309

Largest movements

2024 to 2025
Assets
  • Cash +€215

    up €215 (+3210.7%), from €7 to €222

    mainly Net result for the year (+€739)

Equity and liabilities
  • Profit (loss) carried forward +€739

    up €739 (+34.7%), from -€2,129 to -€1,391

  • Trade debts -€430

    no longer reported in 2025 (was €430)

Income statement
  • Financial income +€1,270

    up €1,270 (+2539680.0%), from €0 to €1,270

  • Gross operating margin +€540

    up €540 (+86.0%), from -€628 to -€88

  • Depreciation -€426

    no longer reported in 2025 (was €426)

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€1,495
Gross operating margin +€540
Depreciation +€426
Other operating charges -€3
Financial income +€1,270
Financial charges +€0
Result 2025 €739

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€215
Investment €0
Financing €0
Cash 2024 €7
Net result for the year +€739
Receivables within one year -€94
Trade debts -€430
Cash 2025 €222
Every line side by side 26 lines
Line Code 2024 2025 Change %
Total assets 20/58 €20,430 €20,739 +€309 +1.5%
Current assets 29/58 €20,430 €20,739 +€309 +1.5%
Amounts receivable within one year 40/41 €20,423 €20,517 +€94 +0.5%
Other amounts receivable 41 €20,423 €20,517 +€94 +0.5%
Cash at bank and in hand 54/58 €7 €222 +€215 +3210.7%
Total equity and liabilities 10/49 €20,430 €20,739 +€309 +1.5%
Equity 10/15 €17,871 €18,609 +€739 +4.1%
Contributions 10/11 €20,000 €20,000 = 0.0%
Profit (loss) carried forward 14 -€2,129 -€1,391 +€739 +34.7%
Amounts payable 17/49 €2,559 €2,129 -€430 -16.8%
Amounts payable within one year 42/48 €2,471 €2,042 -€430 -17.4%
Trade debts 44 €430 - -€430
Suppliers 440/4 €430 - -€430
Other amounts payable 47/48 €2,042 €2,042 = 0.0%
Accrued charges and deferred income 492/3 €88 €88 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €426 - -€426
Other operating charges 640/8 €394 €397 +€3 +0.7%
Gross operating margin 9900 -€628 -€88 +€540 +86.0%
Operating profit (loss) 9901 -€1,448 -€485 +€964 +66.5%
Financial income 75/76B €0 €1,270 +€1,270 +2539680.0%
Recurring financial income 75 €0 €1,270 +€1,270 +2539680.0%
Financial charges 65/66B €46 €46 -€0 0.0%
Recurring financial charges 65 €46 €46 -€0 0.0%
Profit (loss) for the period before taxes 9903 -€1,495 €739 +€2,233
Profit (loss) for the period 9904 -€1,495 €739 +€2,233
Profit (loss) for the period to be appropriated 9905 -€1,495 €739 +€2,233

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.